| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5598243 | Annals of Vascular Surgery | 2017 | 4 Pages |
Abstract
The best treatment strategy for patients with AAA and malignant disease is still not clearly defined. Strategy selection is made individually according to the risk of rupture of AAA, general condition of the patient, experience of the teams that should perform the procedure and estimated life expectancy after resection of malignant disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Slobodan Cvetkovic, Igor Koncar, Daniel Galun, Jelena Ribac, Miroslav Markovic, Nikola Ilic, Marko Dragas, Lazar Davidovic,